Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Operating Leases (2021 - 2026)

Cingulate's (CINGW) quarterly Operating Leases came in at $968455.0 in Q2 2026, down 11.98% quarter-over-quarter from $1.1 million in Q4 2025.

Analysis

Cingulate (CINGW) Operating Leases (2021 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Operating Leases for 6 consecutive years, with $968455.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Leases changed N/A year-over-year to $968455.0; the trailing twelve-month figure through Jun 2026 stood at $968455.0 (changed N/A YoY), and the FY2025 full-year result was $1.1 million, changed N/A from the prior year.
  • Operating Leases slipped to $968455.0 in Q2 2026 per CINGW's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Operating Leases topped out at $1.2 million in Q3 2025 and bottomed at $33145.0 in Q1 2024.
  • Historically, Operating Leases has averaged $568854.0 across 5 years, with a median of $533649.5 in 2022.
  • The sharpest annual moves came in 2022 and 2024: Operating Leases sank 41.01% in 2022, then sank 91.83% in 2024.
  • Over 5 years, Operating Leases stood at $488748.0 in 2022, then tumbled by 73.27% to $130663.0 in 2023, then plunged by 74.63% to $33145.0 in 2024, then soared by 3219.42% to $1.1 million in 2025, then dropped by 11.98% to $968455.0 in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $968455.0, $1.1 million, and $1.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 644.46 Bn 623.70 Bn 17.26 Bn
2 AbbVie 440.11 Bn 433.54 Bn 12.70 Bn
3 Merck 365.04 Bn 357.90 Bn 12.21 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn
6 Sanofi 52.47 Bn 45.09 Bn 10.79 Bn
7 Revolution Medicines 44.26 Bn 44.26 Bn -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn
10 Cingulate 100,214.03 100,214.03 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 968,455.00
Dec 31, 2025 1.10 Mn
Sep 30, 2025 1.16 Mn
Mar 31, 2024 33,145.00
Dec 31, 2023 130,663.00
Sep 30, 2023 225,368.00
Jun 30, 2023 317,343.00
Mar 31, 2023 405,482.00
Dec 31, 2022 488,748.00
Sep 30, 2022 578,551.00
Jun 30, 2022 665,842.00
Mar 31, 2022 749,508.00
Dec 31, 2021 828,503.00